The Power of Lipids: Enhancing Drug Delivery with Nanoparticles

Over the last decade, one of the major challenges faced by pharmaceutical companies across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical drugs approved by regulatory organizations exhibit poor bioavailability / solubility. Further, every year, poor bioavailability is one of the main causes of drug failure in obtaining approval authorization. As a result, the pharmaceutical industry is on the lookout for tools / techniques that can overcome this challenge. Amidst the ongoing initiatives to develop therapeutic interventions with improved bioavailability, lipid nanoparticle (LNPs) have specifically attracted the attention of researchers and drug developers. LNPs are spherical vesicles made up of ionizable lipids that are neutral at physiological pH and positively charged at low pH. LNPs comprise of a lipid bilayer that surrounds a hydrophobic core, which can be loaded with therapeutic agents (such as drugs, genetic material and proteins). The average size of LNPs typically ranges from 40 to 1,000 nanometers, which allows efficient cellular uptake and intracellular delivery.

Lipid Nanoparticles Spherical Vesicles

Types of Lipid Nanoparticle

LNPs can be categorized into solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) the following two types. The choice between SLNs and NLCs depends on factors such as the specific drug, desired drug loading capacity, release profile, and the targeted application.

  • Solid Lipid Nanoparticles: SLNs are sub-micron sized particles made up of a solid lipid matrix that is stabilized by surfactants; further, they have a more ordered and crystalline structure. SLNs offer various benefits, such as easy production process, good release profile and low cost. However, their drawbacks include limited drug loading capacity and potential drug expulsion during storage.
  • Nanostructured Lipid Carriers: NLCs comprise of a mixture of solid and liquid lipids, creating a more structurally flexible lipid matrix. In addition, NLCs offer benefits such as high drug loading capacity, improved drug retention and avoidance of drug expulsion.

Advantages of Lipid Nanoparticle

LNPs are gaining significant attention of formulation scientists in drug delivery due to the various advantages offered by them.

Lipid Nanoparticles Advantages

Preparation Methods of Lipid Nanoparticles

LNPs can be prepared by different methods, that have been presented below.

Lipid Nanoparticles Preparation Methods

Applications of Lipid Nanoparticle

LNPs have a wide range of applications in various fields, including pharmaceuticals, biotechnology and nanomedicine. Some common applications have been described below.

  • Cancer Therapies: LNPs have revolutionized the treatment of different types of cancer by enhancing the anti-cancer activity of chemotherapeutic agents. The coupling of chemotherapeutic agents with LNPs leads to an increase in the drug levels in tumor tissue and decreases the active therapeutic dose, resistance of drugs and toxicity. Several LNP-based therapies are currently being evaluated in the clinical trials; majority of these are conducted for treating breast cancer, ovarian cancer and lung cancer.
  • Gene Therapies: LNPs have the ability to effectively deliver nucleic acids, including small interfering RNA (siRNA), messenger RNA (mRNA), and plasmid DNA to the target cells. They protect these nucleic acids from enzymatic degradation and facilitate their uptake by cells, thereby enabling potential treatment of genetic disorders (Cystic Fibrosis and Duchenne Muscular Dystrophy) as well as non-genetic disorders. In addition, these can be modified with ligands in order to improve the specificity and selectivity of the gene therapy and reduce off-target effects.
  • Vaccines: LNPs have been increasingly used in vaccine development due to their ability to efficiently encapsulate and deliver antigens, that elicit a potent immune response (through antibody production and T-cells activation). Further, they have been extensively utilized in the development of mRNA vaccines for COVID-19. LNPs can also be engineered to encapsulate multiple antigens, enabling the development of multivalent vaccines.
  • Medical Diagnostics: LNPs enable targeted imaging of biological tissues by using various imaging agents, such as contrast agents, fluorescent dyes and radionuclides. The imaging agents can be incorporated into the LNP along with therapeutic agent, allowing for real-time monitoring of drug delivery and distribution. For instance, RNA-based LNPs have been developed for targeted delivery of siRNA to cancer cells; the siRNA can silence genes that are overexpressed in cancer cells, leading to selective cell death. The LNPs can be monitored using various imaging modalities to confirm the delivery of siRNA to the target cells.

Concluding Remarks

LNPs have emerged as a promising class of drug delivery systems that have garnered significant attention in recent years; they play a significant role in the treatment of various disease indications, including cardiovascular disorders, chronic disease, infectious diseases and neurodegenerative diseases. Owing to their ability to encapsulate different types of drugs and genetic materials, LNPs can be utilized for personalized gene therapies, tailored vaccines and targeted drug delivery depending upon the patient’s disease characteristics or genetic makeup. Further, these nanoparticles offer opportunities for combination therapies, wherein multiple therapeutic agents can be encapsulated within a single nanoparticle. This approach can enable synergistic effects, improved therapeutic outcomes, and reduced drug resistance.

For detailed insights about this domain, check out our report on Lipid Nanoparticle Manufacturing Market